TBPH icon

Theravance Biopharma
TBPH

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$29
44% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Oppenheimer
Oppenheimer
Trevor Allred
100% 1-yr TBPH win rate
3 Dec ‘25 1 month ago
BTIG
BTIG
Julian Harrison
100% 1-yr TBPH win rate
26 Nov ‘25 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Douglas Tsao
100% 1-yr TBPH win rate
11 Nov ‘25 2 months ago